Article Text
Education in Heart
Acute coronary syndromes
The vulnerable atherosclerotic plaque: in vivo identification and potential therapeutic avenues
Statistics from Altmetric.com
Footnotes
Contributors PDA wrote the draft. MRD and DEN made substantial contributions in revising the final work.
Funding PDA is supported by the New Zealand Heart Foundation. MRD and DEN are supported by the British Heart Foundation (FS/14/78/31020 and CH/09/002) and the Wellcome Trust (WT103782AIA).
Competing interests None declared.
Provenance and peer review Commissioned; externally peer reviewed.